Immix Biopharma Announces Late-Breaking Nxc-201 Clinical Data Abstract Accepted for Oral Presentation at the 27TH Annual Meeting of the American Society of Gene and Cell Therapy (Asgct)
Immix Biopharma宣布最新发布的Nxc-201临床数据摘要获准在美国基因与细胞疗法学会（Asgct）第27届年会上进行口头陈述